Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cardiomyopathy, Hypertrophic | 37 | 2024 | 1300 | 4.880 |
Why?
|
Cardiomyopathy, Dilated | 24 | 2024 | 819 | 4.400 |
Why?
|
Sarcomeres | 11 | 2020 | 367 | 2.290 |
Why?
|
Uracil | 8 | 2024 | 207 | 1.800 |
Why?
|
Cardiomyopathies | 18 | 2023 | 1945 | 1.790 |
Why?
|
Genetic Testing | 13 | 2022 | 3530 | 1.590 |
Why?
|
Lamin Type A | 10 | 2024 | 187 | 1.340 |
Why?
|
Benzylamines | 9 | 2024 | 248 | 1.280 |
Why?
|
Heart Failure | 26 | 2024 | 11835 | 1.260 |
Why?
|
Desmoplakins | 5 | 2024 | 62 | 1.210 |
Why?
|
Defibrillators, Implantable | 10 | 2022 | 1499 | 1.090 |
Why?
|
Sodium | 4 | 2022 | 1601 | 1.020 |
Why?
|
Tachycardia, Ventricular | 7 | 2024 | 1302 | 0.880 |
Why?
|
Brugada Syndrome | 3 | 2018 | 95 | 0.860 |
Why?
|
Arrhythmogenic Right Ventricular Dysplasia | 2 | 2020 | 162 | 0.810 |
Why?
|
Heart Transplantation | 7 | 2022 | 3217 | 0.770 |
Why?
|
Heart Septum | 3 | 2024 | 303 | 0.740 |
Why?
|
Arrhythmias, Cardiac | 9 | 2024 | 2255 | 0.730 |
Why?
|
Ventricular Function, Left | 14 | 2024 | 3870 | 0.730 |
Why?
|
Cardiomyopathy, Restrictive | 2 | 2022 | 62 | 0.650 |
Why?
|
Online Systems | 1 | 2019 | 181 | 0.630 |
Why?
|
Electrocardiography | 10 | 2020 | 6413 | 0.610 |
Why?
|
Sodium Potassium Chloride Symporter Inhibitors | 2 | 2022 | 150 | 0.610 |
Why?
|
Genes, Dominant | 1 | 2020 | 863 | 0.600 |
Why?
|
Anthracyclines | 1 | 2020 | 283 | 0.590 |
Why?
|
Sarcoidosis | 4 | 2019 | 520 | 0.580 |
Why?
|
Chagas Cardiomyopathy | 2 | 2013 | 71 | 0.530 |
Why?
|
Cardiac Pacing, Artificial | 1 | 2020 | 865 | 0.530 |
Why?
|
Cardiac Resynchronization Therapy | 1 | 2022 | 556 | 0.520 |
Why?
|
Mutation | 20 | 2023 | 29950 | 0.510 |
Why?
|
Trypanosoma cruzi | 2 | 2013 | 206 | 0.470 |
Why?
|
Syncope | 3 | 2013 | 428 | 0.460 |
Why?
|
Stroke Volume | 14 | 2024 | 5513 | 0.450 |
Why?
|
Renal Insufficiency | 1 | 2019 | 820 | 0.450 |
Why?
|
Myocarditis | 3 | 2024 | 766 | 0.440 |
Why?
|
Secondary Prevention | 1 | 2020 | 1548 | 0.440 |
Why?
|
Heterozygote | 7 | 2024 | 2797 | 0.440 |
Why?
|
Atrial Fibrillation | 7 | 2022 | 5201 | 0.420 |
Why?
|
Therapies, Investigational | 1 | 2014 | 111 | 0.420 |
Why?
|
Health Education | 1 | 2019 | 1049 | 0.420 |
Why?
|
Bundle-Branch Block | 2 | 2013 | 281 | 0.410 |
Why?
|
Diuretics | 4 | 2022 | 612 | 0.400 |
Why?
|
Ventricular Dysfunction, Left | 6 | 2023 | 2129 | 0.400 |
Why?
|
Genetic Predisposition to Disease | 16 | 2024 | 17766 | 0.390 |
Why?
|
Genetic Variation | 6 | 2021 | 6540 | 0.390 |
Why?
|
Heart Diseases | 2 | 2022 | 2809 | 0.380 |
Why?
|
Echocardiography | 13 | 2023 | 4980 | 0.380 |
Why?
|
Cardiac Myosins | 3 | 2020 | 124 | 0.370 |
Why?
|
Patient Admission | 1 | 2018 | 1384 | 0.360 |
Why?
|
Middle Aged | 58 | 2024 | 220175 | 0.360 |
Why?
|
Patient Participation | 1 | 2019 | 1437 | 0.350 |
Why?
|
Humans | 110 | 2024 | 760261 | 0.350 |
Why?
|
Furosemide | 3 | 2022 | 170 | 0.340 |
Why?
|
Adult | 55 | 2024 | 219847 | 0.340 |
Why?
|
Disease Management | 3 | 2021 | 2508 | 0.330 |
Why?
|
Phenotype | 14 | 2022 | 16543 | 0.330 |
Why?
|
Magnetic Resonance Imaging, Cine | 5 | 2020 | 1038 | 0.320 |
Why?
|
Muscle Proteins | 3 | 2021 | 1152 | 0.310 |
Why?
|
Male | 70 | 2024 | 359413 | 0.310 |
Why?
|
Death, Sudden, Cardiac | 8 | 2023 | 1572 | 0.310 |
Why?
|
Mortality | 1 | 2020 | 2916 | 0.310 |
Why?
|
Superior Vena Cava Syndrome | 2 | 2018 | 57 | 0.300 |
Why?
|
Hypertension | 4 | 2023 | 8595 | 0.290 |
Why?
|
Heart Defects, Congenital | 2 | 2015 | 4668 | 0.290 |
Why?
|
Female | 71 | 2024 | 391011 | 0.290 |
Why?
|
Registries | 10 | 2024 | 8449 | 0.290 |
Why?
|
Amyloidosis | 1 | 2014 | 818 | 0.280 |
Why?
|
Myocardial Contraction | 1 | 2012 | 1516 | 0.280 |
Why?
|
Alcohol Drinking | 1 | 2020 | 4012 | 0.280 |
Why?
|
Skin | 1 | 2020 | 4468 | 0.280 |
Why?
|
Genetic Counseling | 2 | 2022 | 625 | 0.270 |
Why?
|
Length of Stay | 1 | 2019 | 6472 | 0.260 |
Why?
|
Carrier Proteins | 8 | 2021 | 4938 | 0.250 |
Why?
|
Ventricular Function, Right | 2 | 2024 | 610 | 0.250 |
Why?
|
Ventricular Remodeling | 3 | 2023 | 1259 | 0.240 |
Why?
|
Heart Conduction System | 1 | 2010 | 1016 | 0.240 |
Why?
|
Prognosis | 11 | 2024 | 29636 | 0.240 |
Why?
|
Healthcare Disparities | 1 | 2020 | 3381 | 0.230 |
Why?
|
Indazoles | 2 | 2022 | 302 | 0.230 |
Why?
|
Mass Screening | 1 | 2019 | 5422 | 0.220 |
Why?
|
Aged | 29 | 2024 | 168995 | 0.220 |
Why?
|
Ethylenediamines | 1 | 2022 | 57 | 0.210 |
Why?
|
Muscular Dystrophy, Emery-Dreifuss | 1 | 2022 | 21 | 0.210 |
Why?
|
Hypertrophy, Left Ventricular | 4 | 2023 | 853 | 0.200 |
Why?
|
Family | 4 | 2022 | 3189 | 0.200 |
Why?
|
Muscular Dystrophies, Limb-Girdle | 1 | 2022 | 62 | 0.200 |
Why?
|
Myotonic Dystrophy | 1 | 2022 | 78 | 0.200 |
Why?
|
Risk Assessment | 7 | 2024 | 24086 | 0.190 |
Why?
|
Genotype | 7 | 2022 | 12959 | 0.190 |
Why?
|
Survival Rate | 4 | 2020 | 12806 | 0.180 |
Why?
|
Myosin Heavy Chains | 2 | 2020 | 402 | 0.180 |
Why?
|
Atrioventricular Block | 1 | 2022 | 121 | 0.180 |
Why?
|
Ventricular Outflow Obstruction | 1 | 2023 | 265 | 0.180 |
Why?
|
Protein Kinases | 2 | 2020 | 1612 | 0.170 |
Why?
|
Twins, Monozygotic | 1 | 2021 | 469 | 0.160 |
Why?
|
Adolescent | 18 | 2023 | 87747 | 0.160 |
Why?
|
Urinalysis | 2 | 2018 | 368 | 0.160 |
Why?
|
Young Adult | 17 | 2021 | 58673 | 0.160 |
Why?
|
Fluorodeoxyglucose F18 | 3 | 2019 | 2007 | 0.160 |
Why?
|
Receptors, Somatostatin | 1 | 2019 | 135 | 0.150 |
Why?
|
Muscular Diseases | 1 | 2022 | 551 | 0.150 |
Why?
|
Laryngeal Diseases | 1 | 2020 | 244 | 0.150 |
Why?
|
Victoria | 1 | 2016 | 64 | 0.140 |
Why?
|
Gastric Balloon | 1 | 2017 | 36 | 0.140 |
Why?
|
RNA Splicing | 1 | 2021 | 914 | 0.140 |
Why?
|
Sex Characteristics | 3 | 2022 | 2627 | 0.140 |
Why?
|
Infusions, Intravenous | 2 | 2018 | 2235 | 0.140 |
Why?
|
Retrospective Studies | 13 | 2022 | 80301 | 0.130 |
Why?
|
Disclosure | 1 | 2022 | 738 | 0.130 |
Why?
|
Health Communication | 1 | 2019 | 212 | 0.130 |
Why?
|
Sequence Analysis, DNA | 3 | 2018 | 4717 | 0.130 |
Why?
|
Heart Ventricles | 3 | 2021 | 3811 | 0.130 |
Why?
|
Glycosphingolipids | 1 | 2016 | 75 | 0.130 |
Why?
|
Follow-Up Studies | 7 | 2021 | 39254 | 0.130 |
Why?
|
Calcium Channel Blockers | 2 | 2020 | 694 | 0.130 |
Why?
|
Child | 14 | 2023 | 79758 | 0.130 |
Why?
|
Risk Factors | 14 | 2024 | 74269 | 0.130 |
Why?
|
Airway Obstruction | 1 | 2020 | 660 | 0.130 |
Why?
|
Organometallic Compounds | 1 | 2019 | 659 | 0.130 |
Why?
|
Exons | 1 | 2021 | 2391 | 0.130 |
Why?
|
Double-Blind Method | 7 | 2024 | 12412 | 0.130 |
Why?
|
France | 1 | 2016 | 511 | 0.130 |
Why?
|
Positron-Emission Tomography | 4 | 2019 | 6457 | 0.120 |
Why?
|
Dyspnea | 4 | 2020 | 1352 | 0.120 |
Why?
|
Guillain-Barre Syndrome | 1 | 2016 | 125 | 0.120 |
Why?
|
Child, Preschool | 10 | 2021 | 42034 | 0.120 |
Why?
|
Heart-Assist Devices | 2 | 2020 | 1290 | 0.120 |
Why?
|
Diagnosis, Differential | 4 | 2014 | 12968 | 0.120 |
Why?
|
Diltiazem | 1 | 2014 | 131 | 0.120 |
Why?
|
Mutation, Missense | 2 | 2021 | 2563 | 0.120 |
Why?
|
Heart, Artificial | 1 | 2013 | 107 | 0.110 |
Why?
|
Myocardium | 4 | 2022 | 4688 | 0.110 |
Why?
|
Trypanocidal Agents | 1 | 2013 | 41 | 0.110 |
Why?
|
Otolaryngology | 1 | 2020 | 685 | 0.110 |
Why?
|
Heart | 3 | 2023 | 4392 | 0.110 |
Why?
|
Polymorphism, Genetic | 2 | 2020 | 4286 | 0.110 |
Why?
|
alpha-Galactosidase | 1 | 2013 | 55 | 0.110 |
Why?
|
Acute Disease | 2 | 2024 | 7268 | 0.110 |
Why?
|
Pulmonary Wedge Pressure | 2 | 2011 | 273 | 0.110 |
Why?
|
Incidence | 4 | 2020 | 21378 | 0.100 |
Why?
|
Fabry Disease | 1 | 2013 | 85 | 0.100 |
Why?
|
Prospective Studies | 5 | 2020 | 54263 | 0.100 |
Why?
|
Nitroimidazoles | 1 | 2013 | 117 | 0.100 |
Why?
|
Antibodies, Protozoan | 1 | 2013 | 250 | 0.100 |
Why?
|
Family Health | 1 | 2017 | 1258 | 0.100 |
Why?
|
Hemodynamics | 4 | 2020 | 4169 | 0.100 |
Why?
|
Netherlands | 1 | 2016 | 2213 | 0.100 |
Why?
|
Ambulatory Care Facilities | 1 | 2018 | 926 | 0.100 |
Why?
|
Cost of Illness | 2 | 2018 | 1940 | 0.090 |
Why?
|
Pilot Projects | 3 | 2019 | 8553 | 0.090 |
Why?
|
Triage | 1 | 2018 | 982 | 0.090 |
Why?
|
Heart Valve Diseases | 1 | 2018 | 1047 | 0.090 |
Why?
|
Time Factors | 5 | 2024 | 40133 | 0.090 |
Why?
|
Interleukin-6 | 1 | 2020 | 3207 | 0.090 |
Why?
|
Cardiomegaly | 1 | 2013 | 593 | 0.090 |
Why?
|
Cardiology | 1 | 2021 | 1723 | 0.090 |
Why?
|
Activities of Daily Living | 1 | 2019 | 2414 | 0.090 |
Why?
|
Procollagen | 1 | 2010 | 188 | 0.090 |
Why?
|
Mitral Valve | 1 | 2018 | 1486 | 0.090 |
Why?
|
RNA-Binding Proteins | 1 | 2019 | 1892 | 0.090 |
Why?
|
Treatment Outcome | 8 | 2024 | 64947 | 0.090 |
Why?
|
Tropomyosin | 1 | 2010 | 104 | 0.080 |
Why?
|
Referral and Consultation | 1 | 2022 | 3598 | 0.080 |
Why?
|
Genetic Association Studies | 2 | 2021 | 2716 | 0.080 |
Why?
|
Electric Countershock | 1 | 2012 | 537 | 0.080 |
Why?
|
Interferon-beta | 1 | 2011 | 345 | 0.080 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2018 | 10829 | 0.080 |
Why?
|
Fatigue | 2 | 2016 | 1544 | 0.080 |
Why?
|
C-Reactive Protein | 1 | 2020 | 3822 | 0.080 |
Why?
|
Myosins | 1 | 2010 | 405 | 0.080 |
Why?
|
Biological Assay | 1 | 2011 | 630 | 0.080 |
Why?
|
Medical History Taking | 1 | 2012 | 773 | 0.080 |
Why?
|
Edema | 1 | 2012 | 772 | 0.080 |
Why?
|
Epigenomics | 1 | 2014 | 936 | 0.070 |
Why?
|
Weight Loss | 2 | 2017 | 2683 | 0.070 |
Why?
|
United States | 4 | 2020 | 72363 | 0.070 |
Why?
|
Angina Pectoris, Variant | 1 | 2007 | 56 | 0.070 |
Why?
|
Cohort Studies | 5 | 2020 | 41317 | 0.070 |
Why?
|
Autoantibodies | 1 | 2016 | 2119 | 0.070 |
Why?
|
Epigenesis, Genetic | 1 | 2021 | 3758 | 0.070 |
Why?
|
Echocardiography, Transesophageal | 1 | 2013 | 1108 | 0.070 |
Why?
|
Vena Cava, Superior | 2 | 2018 | 197 | 0.070 |
Why?
|
Health Promotion | 1 | 2019 | 2208 | 0.070 |
Why?
|
Exercise Tolerance | 2 | 2024 | 826 | 0.070 |
Why?
|
Prevalence | 3 | 2024 | 15687 | 0.070 |
Why?
|
Health Surveys | 1 | 2017 | 4061 | 0.070 |
Why?
|
DNA Mutational Analysis | 2 | 2013 | 4109 | 0.070 |
Why?
|
Cardiotonic Agents | 1 | 2009 | 546 | 0.070 |
Why?
|
Troponin | 1 | 2010 | 516 | 0.070 |
Why?
|
Proportional Hazards Models | 1 | 2020 | 12532 | 0.070 |
Why?
|
Obesity, Morbid | 1 | 2017 | 1287 | 0.070 |
Why?
|
Pregnancy | 4 | 2023 | 29725 | 0.070 |
Why?
|
Adrenergic beta-Antagonists | 2 | 2023 | 1256 | 0.060 |
Why?
|
Abdominal Pain | 1 | 2012 | 1064 | 0.060 |
Why?
|
Patient Acceptance of Health Care | 1 | 2019 | 3159 | 0.060 |
Why?
|
Extracellular Matrix | 1 | 2013 | 1726 | 0.060 |
Why?
|
Drug Monitoring | 1 | 2011 | 966 | 0.060 |
Why?
|
Environmental Exposure | 1 | 2020 | 4404 | 0.060 |
Why?
|
Coronary Artery Disease | 2 | 2023 | 6661 | 0.060 |
Why?
|
Quality of Health Care | 1 | 2020 | 4361 | 0.060 |
Why?
|
Cough | 2 | 2018 | 595 | 0.060 |
Why?
|
Hospital Mortality | 1 | 2018 | 5420 | 0.060 |
Why?
|
Coronary Vessel Anomalies | 1 | 2007 | 316 | 0.060 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2009 | 615 | 0.060 |
Why?
|
Primary Prevention | 2 | 2021 | 1207 | 0.060 |
Why?
|
Fibrosis | 3 | 2020 | 2042 | 0.060 |
Why?
|
Aged, 80 and over | 5 | 2020 | 58947 | 0.060 |
Why?
|
Disease Progression | 3 | 2018 | 13505 | 0.050 |
Why?
|
Exercise | 1 | 2020 | 5783 | 0.050 |
Why?
|
Catheter Ablation | 1 | 2016 | 2755 | 0.050 |
Why?
|
Mitogen-Activated Protein Kinase 14 | 1 | 2022 | 29 | 0.050 |
Why?
|
Age Factors | 3 | 2019 | 18415 | 0.050 |
Why?
|
Cardiovascular Diseases | 2 | 2019 | 15740 | 0.050 |
Why?
|
Health Services Accessibility | 1 | 2020 | 5396 | 0.050 |
Why?
|
Quality of Life | 3 | 2023 | 13300 | 0.050 |
Why?
|
Immunologic Factors | 1 | 2011 | 1589 | 0.050 |
Why?
|
Denmark | 1 | 2024 | 759 | 0.050 |
Why?
|
Infant | 3 | 2020 | 36030 | 0.050 |
Why?
|
Severity of Illness Index | 5 | 2020 | 15827 | 0.050 |
Why?
|
Age of Onset | 2 | 2020 | 3302 | 0.050 |
Why?
|
Antibodies, Neutralizing | 1 | 2011 | 1933 | 0.050 |
Why?
|
Immunoglobulin G | 1 | 2013 | 4546 | 0.050 |
Why?
|
Glycine | 1 | 2024 | 663 | 0.050 |
Why?
|
Heart Rate | 1 | 2012 | 4169 | 0.050 |
Why?
|
Oligonucleotides | 1 | 2023 | 588 | 0.040 |
Why?
|
Catheters | 1 | 2023 | 425 | 0.040 |
Why?
|
Imaging, Three-Dimensional | 1 | 2013 | 4044 | 0.040 |
Why?
|
Myofibrils | 1 | 2020 | 141 | 0.040 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2022 | 629 | 0.040 |
Why?
|
Pedigree | 2 | 2017 | 4577 | 0.040 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2020 | 412 | 0.040 |
Why?
|
Radiopharmaceuticals | 2 | 2019 | 2633 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 3 | 2019 | 36247 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2023 | 10340 | 0.040 |
Why?
|
Validation Studies as Topic | 1 | 2019 | 163 | 0.040 |
Why?
|
KCNQ1 Potassium Channel | 1 | 2019 | 103 | 0.040 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2020 | 363 | 0.040 |
Why?
|
Brachiocephalic Veins | 1 | 2018 | 21 | 0.040 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2022 | 859 | 0.040 |
Why?
|
Pharynx | 1 | 2020 | 432 | 0.040 |
Why?
|
Papillary Muscles | 1 | 2018 | 192 | 0.040 |
Why?
|
Alleles | 2 | 2021 | 6900 | 0.040 |
Why?
|
Peptide Fragments | 1 | 2010 | 5120 | 0.040 |
Why?
|
Cross-Over Studies | 1 | 2023 | 2061 | 0.040 |
Why?
|
Stroke | 1 | 2020 | 9945 | 0.040 |
Why?
|
Causality | 1 | 2023 | 1241 | 0.040 |
Why?
|
Campylobacter Infections | 1 | 2016 | 31 | 0.030 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2017 | 225 | 0.030 |
Why?
|
Calcium | 1 | 2010 | 5726 | 0.030 |
Why?
|
Epicardial Mapping | 1 | 2016 | 56 | 0.030 |
Why?
|
Gene Duplication | 1 | 2017 | 314 | 0.030 |
Why?
|
Multiple Sclerosis | 1 | 2011 | 3202 | 0.030 |
Why?
|
Interleukin-10 | 1 | 2020 | 1174 | 0.030 |
Why?
|
Neural Conduction | 1 | 2016 | 441 | 0.030 |
Why?
|
Combined Modality Therapy | 2 | 2021 | 8551 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 2 | 2017 | 20484 | 0.030 |
Why?
|
Vinculin | 1 | 2014 | 59 | 0.030 |
Why?
|
Germany | 1 | 2016 | 875 | 0.030 |
Why?
|
Oxygen Consumption | 1 | 2020 | 1840 | 0.030 |
Why?
|
Recovery of Function | 1 | 2024 | 2982 | 0.030 |
Why?
|
Cardiovascular Agents | 1 | 2020 | 864 | 0.030 |
Why?
|
Thrombosis | 2 | 2018 | 3052 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2019 | 14656 | 0.030 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2022 | 1705 | 0.030 |
Why?
|
Analysis of Variance | 2 | 2013 | 6242 | 0.030 |
Why?
|
Professional-Family Relations | 1 | 2017 | 495 | 0.030 |
Why?
|
Collagen | 2 | 2013 | 2635 | 0.030 |
Why?
|
Parents | 2 | 2017 | 3547 | 0.030 |
Why?
|
Exercise Test | 1 | 2020 | 2125 | 0.030 |
Why?
|
Abnormalities, Multiple | 1 | 2020 | 1415 | 0.030 |
Why?
|
Hepatomegaly | 1 | 2012 | 84 | 0.030 |
Why?
|
Blood Urea Nitrogen | 1 | 2012 | 187 | 0.030 |
Why?
|
Pyrimidines | 1 | 2024 | 3011 | 0.030 |
Why?
|
Diastole | 1 | 2014 | 788 | 0.020 |
Why?
|
Catheterization, Swan-Ganz | 1 | 2012 | 87 | 0.020 |
Why?
|
Codon, Nonsense | 1 | 2013 | 282 | 0.020 |
Why?
|
Hemolysis | 1 | 2013 | 423 | 0.020 |
Why?
|
Amiodarone | 1 | 2013 | 218 | 0.020 |
Why?
|
Health Status | 1 | 2024 | 4081 | 0.020 |
Why?
|
Pulsatile Flow | 1 | 2012 | 320 | 0.020 |
Why?
|
London | 1 | 2011 | 234 | 0.020 |
Why?
|
Jugular Veins | 1 | 2012 | 211 | 0.020 |
Why?
|
Ascites | 1 | 2012 | 338 | 0.020 |
Why?
|
Troponin I | 1 | 2014 | 634 | 0.020 |
Why?
|
Echocardiography, Doppler, Pulsed | 1 | 2009 | 69 | 0.020 |
Why?
|
Response Elements | 1 | 2011 | 308 | 0.020 |
Why?
|
Vomiting | 1 | 2013 | 649 | 0.020 |
Why?
|
Gadolinium DTPA | 1 | 2013 | 826 | 0.020 |
Why?
|
Sex Factors | 1 | 2023 | 10530 | 0.020 |
Why?
|
Luciferases | 1 | 2011 | 716 | 0.020 |
Why?
|
Gene Frequency | 1 | 2016 | 3605 | 0.020 |
Why?
|
Respiration, Artificial | 1 | 2020 | 2623 | 0.020 |
Why?
|
Education, Medical, Graduate | 1 | 2021 | 2359 | 0.020 |
Why?
|
Echocardiography, Doppler | 1 | 2013 | 900 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 3804 | 0.020 |
Why?
|
Heart Function Tests | 1 | 2009 | 319 | 0.020 |
Why?
|
Critical Care | 1 | 2021 | 2699 | 0.020 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2013 | 784 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2019 | 5201 | 0.020 |
Why?
|
Cause of Death | 1 | 2018 | 3723 | 0.020 |
Why?
|
Sequence Deletion | 1 | 2012 | 1493 | 0.020 |
Why?
|
Genes, Reporter | 1 | 2011 | 1531 | 0.020 |
Why?
|
Coronary Vasospasm | 1 | 2007 | 83 | 0.020 |
Why?
|
Hospitalization | 2 | 2020 | 10761 | 0.020 |
Why?
|
Multicenter Studies as Topic | 1 | 2012 | 1723 | 0.020 |
Why?
|
Collagen Type I | 1 | 2010 | 615 | 0.020 |
Why?
|
Logistic Models | 2 | 2013 | 13311 | 0.020 |
Why?
|
Coronary Angiography | 2 | 2010 | 4560 | 0.020 |
Why?
|
GTP-Binding Proteins | 1 | 2011 | 951 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2013 | 15273 | 0.020 |
Why?
|
Patient Selection | 1 | 2017 | 4276 | 0.020 |
Why?
|
Ambulatory Care | 1 | 2016 | 2783 | 0.020 |
Why?
|
Genome, Human | 1 | 2017 | 4416 | 0.010 |
Why?
|
Massachusetts | 1 | 2017 | 8805 | 0.010 |
Why?
|
Probability | 1 | 2009 | 2476 | 0.010 |
Why?
|
Case-Control Studies | 2 | 2013 | 22041 | 0.010 |
Why?
|
Recurrence | 1 | 2016 | 8487 | 0.010 |
Why?
|
Communication | 1 | 2017 | 3846 | 0.010 |
Why?
|
Transfection | 1 | 2011 | 5782 | 0.010 |
Why?
|
Databases, Factual | 1 | 2018 | 8018 | 0.010 |
Why?
|
Anticoagulants | 1 | 2018 | 4896 | 0.010 |
Why?
|
Radiography | 1 | 2013 | 6965 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2019 | 20048 | 0.010 |
Why?
|
Animals | 1 | 2012 | 167940 | 0.010 |
Why?
|
Inflammation | 1 | 2020 | 10757 | 0.010 |
Why?
|
Contrast Media | 1 | 2013 | 5301 | 0.010 |
Why?
|
Aorta | 1 | 2007 | 2042 | 0.010 |
Why?
|
Body Mass Index | 1 | 2017 | 12901 | 0.010 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2013 | 2296 | 0.010 |
Why?
|
Postoperative Complications | 2 | 2013 | 15680 | 0.010 |
Why?
|
Peptides | 1 | 2010 | 4358 | 0.010 |
Why?
|
Kidney Transplantation | 1 | 2013 | 4215 | 0.010 |
Why?
|
Algorithms | 1 | 2017 | 13967 | 0.010 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2007 | 1455 | 0.010 |
Why?
|
Chronic Disease | 1 | 2011 | 9283 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2011 | 16905 | 0.010 |
Why?
|
Blood Pressure | 1 | 2009 | 8523 | 0.010 |
Why?
|
Comorbidity | 1 | 2007 | 10552 | 0.010 |
Why?
|